Harbour Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Harbour Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,305	Closed	-$562K	–	259
2018 Q1	$562K	Sell	5,305 -5,314	-50%	-$617K	0.24%	121
2017 Q4	$1.24M	Sell	10,619 -726	-6%	-$82.1K	0.52%	63
2017 Q3	$1.29M	Buy	11,345 +896	+9%	+$103K	0.56%	47
2017 Q2	$1.3M	Buy	10,449 +309	+3%	+$36.6K	0.65%	45
2017 Q1	$1.2M	Hold	10,140	–	–	0.55%	48
2016 Q4	$1.02M	Buy	10,140 +1,910	+23%	+$205K	0.73%	46
2016 Q3	$1.04M	Buy	8,230 +1,174	+17%	+$145K	0.65%	43
2016 Q2	$825K	Sell	7,056 -15	-0.2%	-$1.7K	0.46%	75
2016 Q1	$732K	Buy	7,071 +1,869	+36%	+$181K	0.42%	80
2015 Q4	$518K	Buy	+5,202	New	+$509K	0.28%	120

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Harbour Capital Advisors's ZBH Position: Q2 2018 in Review

Harbour Capital Advisors sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 5,305 shares — an estimated $562K sold.

Harbour Capital Advisors first reported a position in ZBH in Q4 2015 and held it in 10 quarters. The position peaked at $1.3M in Q2 2017. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

Harbour Capital Advisors reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
Harbour Capital Advisors sold 5,305 Zimmer Biomet shares in Q2 2018, an estimated $562K.
Harbour Capital Advisors first reported a position in Zimmer Biomet in Q4 2015 and held it in 10 quarters.
Harbour Capital Advisors's Zimmer Biomet position peaked at $1.3M in Q2 2017.
869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Harbour Capital Advisors's 13F filing for Q2 2018, filed 11 Jul 2018.